Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education

June 5, 2013 updated by: Thomas Fuehner, Hannover Medical School

Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education - a Randomized Open Controlled Trial

Experimental intervention:

Patient education after lung transplantation via Tablet computers. An electronic patient questionnaire via tablet computer will be collected in addition.

Control intervention:

Conventional Patient education by health care professionals. A paper-based patient questionnaire will be provided.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Noncompliance with immunosuppressive medications after organ transplantation is thought to be a leading cause of allograft rejection, graft loss, and death. Immunosuppressant medy to prevent graft rejection after lung transplantation.

Reported non-compliance rates with calcineurin inhibitors are ranging between 13 and 22 % after lung transplantation. Incidence of non-compliance increases over time after transplantation. Increased health care costs, decreased quality of life, and organ failure (incl. the need for re-do transplantation) are possible consequences of immunosuppressant noncompliance. Therefore, medication compliance defined as the extent to which a patient's medication taking behaviour coincides with the prescribed regimen, is a critical issue in transplantation. Repeated patient education is one option to overcome non-adherence and immunosuppressive medication non-compliance.

Immunosuppressive therapy is monitored by measurement of drug levels. Fluctuating drug levels increase the risk for rejection and drug toxicities. In addition, frequent dose adjustments, case management and frequent monitoring of drug levels are cost-intensive.

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lower Saxony
      • Hanover, Lower Saxony, Germany, 30625
        • Hanover Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients at least 6 months after lung transplantation (single, double or combined)
  • Informed consent
  • At least 10 trough levels analyzed in MHH reference lab in last 6 months
  • < 50% of calcineurin inhibitor trough levels in target range in last 6 months in outpatient clinic

Exclusion Criteria:

  • Hospitalization during last 3 months
  • BOS stage 3 (FEV1 < 50% baseline)
  • End stage kidney disease (GFR <15 ml/min/1.73 m2 or renal replacement therapy)
  • Oxygen requirement at rest
  • Steroid pulse therapy (>500 mg methylprednisolone per day) during the last 4 weeks
  • Illiteracy
  • Need for isolation (Colonization with multi. or pan resistant organisms, e.g. MRSA, B. cenocepacia)
  • limited German language skills or other reasons which might impair patient communication or computer handling

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional Patient education
Conventional Patient education by health care professionals.
Patient education by health care professional compared to education via tablet PC
Experimental: Patient education via Tablet computer
Patient education after lung transplantation via Tablet computers. An electronic patient questionnaire via tablet computer will be collected in addition.
Patient education by health care professional compared to education via tablet PC

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Calcineurin trough levels
Time Frame: 6 month
Improvement of percentage of calcineurin inhibitor trough levels (Delta %) in target range 6 months after patient education compared to 6 months before patient education
6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Calcineurin trough levels variability
Time Frame: 6 month
Trough level variability 6 months after patient education compared to 6 months before patient education
6 month
Interval Adherence
Time Frame: 6 month
interval adherence (number of measurements vs. recommended measurements) 6 months after patient education compared to 6 months before patient education
6 month
Trough level interval
Time Frame: 6 month
Interval of trough level measurement variability 6 months after patient education compared to 6 months before patient education
6 month
Total time of education
Time Frame: 6 month
Total time of education
6 month
Total time of answering questionnaire
Time Frame: 6 month
Total time of answering questionnaire
6 month
Knowledge Improvement
Time Frame: 6 month
Improvement of patient knowledge on immunosuppressive after patient education
6 month
Self rated adherence
Time Frame: 6 month
Self rated adherence to immunosuppressive medication (BAASIS scale)
6 month
Adherence
Time Frame: 6 month
Therapy adherence 6 months after patient education compared to 6 months before patient education
6 month
Glomerular filtration rate
Time Frame: 6 month
Glomerular filtration rate 6 months after patient education compared to baseline (CKD-EPI)
6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jens T Gottlieb, MD, Hannover Medical School

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2011

Primary Completion (Actual)

July 1, 2012

Study Completion (Actual)

May 1, 2013

Study Registration Dates

First Submitted

July 5, 2011

First Submitted That Met QC Criteria

July 19, 2011

First Posted (Estimate)

July 20, 2011

Study Record Updates

Last Update Posted (Estimate)

June 6, 2013

Last Update Submitted That Met QC Criteria

June 5, 2013

Last Verified

June 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • V 2.0 16/03/2011

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lung Transplantation

Clinical Trials on Patient education

3
Subscribe